Key Highlights
- Shares of Rocket Lab advanced approximately 1.1% to $75.67, reaching an intraday peak of $80.19
- The aerospace firm successfully executed its 92nd Electron launch, marking the 13th mission in 2026
- A $397 million Space Force contract was secured for the SB-AMTI satellite initiative using Flatellite spacecraft
- Combined recent Space Force agreements total roughly $663 million, contributing to a backlog near $2.2 billion
- Second quarter 2026 financial results are scheduled for August 10; Wall Street forecasts revenue of $231.79 million versus $144.50 million year-over-year
Shares of Rocket Lab experienced upward momentum Thursday, peaking at $80.19 during the session before closing near $75.67, representing a gain of approximately 1.1% from Wednesday’s finish at $74.82.
The stock’s advance followed an eventful period for the aerospace company, marked by a successful orbital deployment and multiple high-value government contract announcements that rekindled investor interest.
The company’s 92nd Electron launch took place Thursday from its New Zealand facility in Mahia. This deployment represented the eighth mission supporting the IQPS Earth observation constellation and marked the company’s 13th Electron flight this year.
The United States Space Force granted Rocket Lab a $397 million agreement to design, launch, and manage Flatellite satellites as part of the Space-Based Airborne Moving Target Indicator initiative. The Flatellite system targets deployment in extensive satellite networks.
Together with an additional major launch services agreement, Rocket Lab’s cumulative Space Force contract awards over recent weeks totaled around $663 million. The firm’s current backlog sits at approximately $2.2 billion.
Several SB-AMTI launches will require Rocket Lab’s Neutron launch vehicle, which remains in development and has not yet completed its inaugural flight.
Wall Street Perspective
Analyst sentiment toward the stock leans optimistic. The consensus recommendation stands at “Moderate Buy” with a mean price objective of $110.29 among analysts monitored by MarketBeat. KeyCorp holds the highest target at $135, while Piper Sandler maintains the most conservative stance with a Neutral rating and an $83 projection.
KGI Securities elevated Rocket Lab to Outperform on July 27, establishing a $107 price objective. Bank of America increased its target from $105 to $115 in late June while reaffirming its Buy recommendation.
Upcoming Financial Report
Investor focus now shifts to August 10, when Rocket Lab will unveil its Q2 2026 financial performance following market close. Wall Street anticipates a per-share loss of 7 cents, an improvement from the 13 cent loss recorded in the corresponding quarter last year.
Revenue projections stand at $231.79 million, reflecting substantial growth from the $144.50 million reported a year earlier.
During Q1 2026, Rocket Lab delivered revenue of $200.35 million, representing 63.4% year-over-year expansion and surpassing analyst projections of $189.65 million.
The company commands a market capitalization of $43.79 billion and currently trades at a negative P/E ratio of -236.47. Its beta coefficient of 2.60 underscores the heightened volatility characteristic of the stock.
Company insiders have divested more than 3.8 million shares valued at approximately $362.8 million during the past three months. Chief Executive Peter Beck sold 990,960 shares on July 8 at an average transaction price of $82.86, trimming his ownership position by 36.5%.
The equity’s 50-day moving average rests at $91.53, while its 200-day moving average stands at $85.99, both positioned above current trading levels.
Institutional investors control 71.78% of outstanding shares, with Bank of New York Mellon Corp establishing a new position valued at roughly $201.5 million during Q2.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
